Princeton Alpha Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-8,035
Closed -$1.32M 31
2017
Q1
$1.32M Sell
8,035
-13,126
-62% -$2.18M 0.44% 41
2016
Q4
$3.09M Buy
+21,161
New +$3.18M 0.64% 16
2016
Q3
Sell
-36,468
Closed -$5.55M 734
2016
Q2
$5.55M Buy
36,468
+28,768
+374% +$4.47M 0.99% 4
2016
Q1
$1.15M Buy
+7,700
New +$1.14M 0.19% 174
2015
Q4
Sell
-6,394
Closed -$884K 702
2015
Q3
$884K Sell
6,394
-12,975
-67% -$2.05M 0.18% 162
2015
Q2
$2.97M Buy
19,369
+8,571
+79% +$1.37M 0.59% 18
2015
Q1
$1.73M Sell
10,798
-1,999
-16% -$315K 0.37% 57
2014
Q4
$2.04M Buy
+12,797
New +$1.99M 0.57% 16
2014
Q2
Sell
-9,966
Closed -$1.23M 668
2014
Q1
$1.23M Buy
+9,966
New +$1.21M 0.38% 43

Other funds holding AMGN

Princeton Alpha Management's AMGN Position: Q2 2017 in Review

Princeton Alpha Management sold out of Amgen (AMGN) in Q2 2017, closing a stake of 8,035 shares — an estimated $1.32M sold.

Princeton Alpha Management first reported a position in AMGN in Q1 2014 and held it in 9 quarters. The position peaked at $5.55M in Q2 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Princeton Alpha Management reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 8,035 Amgen shares in Q2 2017, an estimated $1.32M.
  • Princeton Alpha Management first reported a position in Amgen in Q1 2014 and held it in 9 quarters.
  • Princeton Alpha Management's Amgen position peaked at $5.55M in Q2 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.